IRIS Accounts Production v24.3.0.553 03323693 Board of Directors 1.6.23 31.5.24 31.5.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh033236932023-05-31033236932024-05-31033236932023-06-012024-05-31033236932022-05-31033236932022-06-012023-05-31033236932023-05-3103323693ns15:EnglandWales2023-06-012024-05-3103323693ns14:PoundSterling2023-06-012024-05-3103323693ns10:Director12023-06-012024-05-3103323693ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3103323693ns10:SmallEntities2023-06-012024-05-3103323693ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3103323693ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3103323693ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3103323693ns10:FullAccounts2023-06-012024-05-310332369312023-06-012024-05-3103323693ns10:OrdinaryShareClass12023-06-012024-05-3103323693ns10:Director22023-06-012024-05-3103323693ns10:Director32023-06-012024-05-3103323693ns10:RegisteredOffice2023-06-012024-05-3103323693ns5:CurrentFinancialInstruments2024-05-3103323693ns5:CurrentFinancialInstruments2023-05-3103323693ns5:Non-currentFinancialInstruments2024-05-3103323693ns5:Non-currentFinancialInstruments2023-05-3103323693ns5:ShareCapital2024-05-3103323693ns5:ShareCapital2023-05-3103323693ns5:RetainedEarningsAccumulatedLosses2024-05-3103323693ns5:RetainedEarningsAccumulatedLosses2023-05-3103323693ns5:NetGoodwill2023-06-012024-05-3103323693ns5:LeaseholdImprovements2023-06-012024-05-3103323693ns5:PlantMachinery2023-06-012024-05-3103323693ns5:FurnitureFittings2023-06-012024-05-3103323693ns5:MotorVehicles2023-06-012024-05-3103323693ns5:ComputerEquipment2023-06-012024-05-3103323693ns5:NetGoodwill2023-05-3103323693ns5:NetGoodwill2024-05-3103323693ns5:NetGoodwill2023-05-3103323693ns5:PlantMachinery2023-05-3103323693ns5:PlantMachinery2024-05-3103323693ns5:PlantMachinery2023-05-3103323693ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-05-3103323693ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-06-012024-05-3103323693ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-05-3103323693ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-05-3103323693ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-05-3103323693ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3103323693ns10:OrdinaryShareClass12024-05-31
REGISTERED NUMBER: 03323693 (England and Wales)














UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2024

FOR

M & M MEDICAL LIMITED

M & M MEDICAL LIMITED (REGISTERED NUMBER: 03323693)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


M & M MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2024







DIRECTORS: Mr M J Tiffin
Mr P Sayer
Mr P J Chappell





REGISTERED OFFICE: Unit B4 Heol Y Twyn
Talbot Green Business Park
Talbot Green
Mid Glamorgan
CF72 9FG





REGISTERED NUMBER: 03323693 (England and Wales)





ACCOUNTANTS: Sullivans Chartered Accountants
13-14 Gelliwastad Road
Pontypridd
Rhondda Cynon Taf
CF37 2BW

M & M MEDICAL LIMITED (REGISTERED NUMBER: 03323693)

STATEMENT OF FINANCIAL POSITION
31 MAY 2024

31/5/24 31/5/23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Property, plant and equipment 5 342,383 84,527
342,383 84,527

CURRENT ASSETS
Inventories 79,406 81,730
Debtors 6 507,054 930,514
Cash at bank and in hand 1,538,979 1,133,154
2,125,439 2,145,398
CREDITORS
Amounts falling due within one year 7 531,205 561,044
NET CURRENT ASSETS 1,594,234 1,584,354
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,936,617

1,668,881

CREDITORS
Amounts falling due after more than one year 8 (187,115 ) -

PROVISIONS FOR LIABILITIES (60,273 ) (6,396 )
NET ASSETS 1,689,229 1,662,485

CAPITAL AND RESERVES
Called up share capital 10 2 2
Retained earnings 1,689,227 1,662,483
SHAREHOLDERS' FUNDS 1,689,229 1,662,485

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

M & M MEDICAL LIMITED (REGISTERED NUMBER: 03323693)

STATEMENT OF FINANCIAL POSITION - continued
31 MAY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 December 2024 and were signed on its behalf by:





Mr M J Tiffin - Director


M & M MEDICAL LIMITED (REGISTERED NUMBER: 03323693)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024

1. STATUTORY INFORMATION

M & M Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

No material uncertainties that may cast significant doubt about the ability of the company to continue as a going concern have been identified by the directors.

Therefore the financial statements have been prepared on a going concern basis.

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax, except in respect of service contracts where turnover is recognised when the company obtains the right to consideration.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 1999 was being amortised evenly over its estimated useful life of twenty years.
The amount brought forward from 2015 has been amortised over its maximum useful life of 5 years in accordance with FRS 102 (Section 1a).

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Improvements to property - 10% on cost
Plant and machinery - 20% on cost
Fixtures and fittings - 10% on cost
Motor vehicles - 25% on cost
Computer equipment - 33% on cost

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


M & M MEDICAL LIMITED (REGISTERED NUMBER: 03323693)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 21 (2023 - 20 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 June 2023
and 31 May 2024 114,245
AMORTISATION
At 1 June 2023
and 31 May 2024 114,245
NET BOOK VALUE
At 31 May 2024 -
At 31 May 2023 -

M & M MEDICAL LIMITED (REGISTERED NUMBER: 03323693)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

5. PROPERTY, PLANT AND EQUIPMENT
Plant and
machinery
etc
£   
COST
At 1 June 2023 470,696
Additions 346,748
Disposals (176,468 )
At 31 May 2024 640,976
DEPRECIATION
At 1 June 2023 386,169
Charge for year 75,403
Eliminated on disposal (162,979 )
At 31 May 2024 298,593
NET BOOK VALUE
At 31 May 2024 342,383
At 31 May 2023 84,527

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 June 2023 152,994
Additions 302,894
Disposals (121,720 )
At 31 May 2024 334,168
DEPRECIATION
At 1 June 2023 149,694
Charge for year 44,147
Eliminated on disposal (121,720 )
At 31 May 2024 72,121
NET BOOK VALUE
At 31 May 2024 262,047
At 31 May 2023 3,300

M & M MEDICAL LIMITED (REGISTERED NUMBER: 03323693)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/5/24 31/5/23
£    £   
Trade debtors 332,260 549,761
Amounts recoverable on contract 156,189 295,510
Other debtors 18,605 85,243
507,054 930,514

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/5/24 31/5/23
£    £   
Hire purchase contracts 41,558 8,272
Trade creditors 212,523 255,291
Amounts owed to group undertakings 1,544 2,231
Taxation and social security 105,308 139,583
Other creditors 170,272 155,667
531,205 561,044

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31/5/24 31/5/23
£    £   
Hire purchase contracts 187,115 -

9. SECURED DEBTS

The following secured debts are included within creditors:

31/5/24 31/5/23
£    £   
Hire purchase contracts 228,673 8,272

Hire purchase liabilities are secured against the assets to which they relate.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31/5/24 31/5/23
value: £    £   
2 Ordinary £1 2 2

11. ULTIMATE CONTROLLING PARTY

The company was owned by M&M Medical Group Limited, by virtue of its 100% shareholding, from 25th July 2019.